doheny ucla logo.png
Doheny Eye Institute Announces Upcoming Presentations at ARVO 2024 Annual Meeting
April 24, 2024 09:00 ET | Doheny Eye Institute
PASADENA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that more than 25 of its scientists and...
RTGN and TAG transparent 2023-12-04_15-50-47.png
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy
February 22, 2024 06:05 ET | RetinalGeniX Technologies, Inc.
RetinalGeniX Granted A New Patent for an Affordable and Effective Device and Method To Detect Ocular And Systemic Diseases
roche-logo-blue.png
New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
February 01, 2024 01:03 ET | F. Hoffmann-La Roche Ltd
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision Up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months...
DEI Logo (1).png
Doheny Eye Institute Research Breakthrough: An Inherited Mutation Blinds Young Adult Males By Disturbing Mitochondrial Quantum Electron Tunneling
January 29, 2024 12:05 ET | Doheny Eye Institute
PASADENA, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, is pleased to announce the publication of important new findings...
RetinalGeniX Logo Revised Sept 2023.jpg
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
December 01, 2023 12:32 ET | RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC. ANNOUNCES HIRING OF INTERIM CFO Virender Ahluwalia will serve as Interim Chief Financial Officer
Corza Medical's Ophthalmology Center of Technology and Innovation
Corza Medical Opens State-of-the-Art Ophthalmology Center of Technology and Innovation, Demonstrating Commitment to Global Eye Care Community
November 30, 2023 08:05 ET | Corza Medical Inc.
Corza Medical opens a new Ophthalmology Center of Technology and Innovation in MO to develop next-gen devices for eye treatments and enhance R&D.
retinai_logo_RGB_black (1).png
RetinAI Joins Forces with Stephen J. Ryan Initiative for Macular Research (RIMR) AMD Consortium to Forge a Global Retinal Imaging initiative Targeting Research in AMD
November 29, 2023 03:00 ET | RetinAI Medical AG
BERN, Switzerland and BOSTON, Nov. 29, 2023 (GLOBE NEWSWIRE) -- RetinAI Medical AG (“RetinAI”), a leader in clinical and imaging data management software and advanced analytics using artificial...
DEI Logo (1).png
Stiffening of retinal blood vessels threatens vision in diabetes
November 21, 2023 08:00 ET | Doheny Eye Institute
PASADENA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Doheny Eye Institute, a pioneer in vision research, is pleased to announce the publication of a novel approach to early diabetic retinopathy...
IIA Logo_Segment-Beauty.png
SBLA BEAUTY Eye Lift Wand Recognized With “Eye Treatment Product Of The Year ” Award From Beauty Innovation
November 15, 2023 08:00 ET | Beauty Innovation Awards
LOS ANGELES, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The 2023 Beauty Innovation Awards today announced that the Eye Lift Wand from SBLA BEAUTY has been selected as “Eye Treatment Product Of The Year” in...
New Logo.png
Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal Melanoma
November 13, 2023 08:00 ET | Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal...